<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04993612</url>
  </required_header>
  <id_info>
    <org_study_id>21-063</org_study_id>
    <nct_id>NCT04993612</nct_id>
  </id_info>
  <brief_title>Postcapillary Blood Gas Analysis in Wedge Position (Wedge-BGA)</brief_title>
  <official_title>Blood Gas Analysis Obtained in Pulmonary Capillary Wedge Position During Right Heart Catheterization</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ayham Daher</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>RWTH Aachen University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      If pulmonary hypertension is suspected, a right heart catheterization is usually performed to&#xD;
      confirm or rule out the diagnosis. As part of this examination, blood samples are taken from&#xD;
      various locations as standard and blood gas analyses are performed. One of the most important&#xD;
      measurements during the right heart catheterization is the measurement of the pulmonary&#xD;
      arterial occlusion pressure by the so-called wedge maneuver. To measure this value, the&#xD;
      catheter with inflated balloon must be advanced into the pulmonary vessels until the &quot;wedge&quot;&#xD;
      position is reached, i.e. the balloon completely occludes a branch of the pulmonary artery.&#xD;
      In this study, the investigators want to characterize patients with pulmonary hypertension of&#xD;
      different causes in more detail. To do that, two blood samples (totaling approximately 4 mL&#xD;
      of blood, one sample directly after occlusion and the other one two minutes later) will be&#xD;
      drawn during the right heart catheterization from the above-mentioned &quot;wedge&quot; position&quot;,&#xD;
      behind the inflated balloon, and blood gas analyses will be performed on these samples. In&#xD;
      addition, various clinical parameters (comorbidities, etc.) will be recorded by means of&#xD;
      clinical questionnaires. Follow-up data will be analyzed and correlations with the&#xD;
      aforementioned blood gas analyses will be examined. The results of the study will be used to&#xD;
      more precisely characterize the still vague concept of secondary pulmonary hypertension. This&#xD;
      could help to develop new therapeutic strategies in some subgroups in the future.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 25, 2021</start_date>
  <completion_date type="Anticipated">June 30, 2023</completion_date>
  <primary_completion_date type="Anticipated">June 30, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Risk group after 3-6 months</measure>
    <time_frame>3-6 months</time_frame>
    <description>Standardized clinical outcome parameters after 3-6 months</description>
  </primary_outcome>
  <number_of_groups>6</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Pulmonary Hypertension</condition>
  <arm_group>
    <arm_group_label>No pulmonary Hypertension</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>pulmonary Hypertension Group 1</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>pulmonary Hypertension Group 2</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>pulmonary Hypertension Group 3</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>pulmonary Hypertension Group 4</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>pulmonary Hypertension Group 5</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Blood gas analysis</intervention_name>
    <description>Two blood samples will be drawn from the &quot;wedge&quot; position&quot;, behind the inflated balloon, during the right heart catheterization, and blood gas analyses will be performed. First sample will be drawn directly after inflating the ballon, and the second one 2 minutes later.</description>
    <arm_group_label>No pulmonary Hypertension</arm_group_label>
    <arm_group_label>pulmonary Hypertension Group 1</arm_group_label>
    <arm_group_label>pulmonary Hypertension Group 2</arm_group_label>
    <arm_group_label>pulmonary Hypertension Group 3</arm_group_label>
    <arm_group_label>pulmonary Hypertension Group 4</arm_group_label>
    <arm_group_label>pulmonary Hypertension Group 5</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All patients receiving right heart catheterization for appropriate indications will be&#xD;
        interviewed for their consent to participate in the study&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients who have a clearly defined indication for Right heart catheterization.&#xD;
&#xD;
          -  Age &gt; 18 years&#xD;
&#xD;
          -  Informed consent for participation in the study will sign&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Individuals who are not fully capable of giving consent and understanding the nature,&#xD;
             significance, and scope of the study&#xD;
&#xD;
          -  Pregnancy and lactation&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>99 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University Hospital RWTH Aachen</name>
      <address>
        <city>Aachen</city>
        <zip>52062</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ayham Daher, M.D.</last_name>
      <phone>+492418088763</phone>
      <email>adaher@ukaachen.de</email>
    </contact>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>July 30, 2021</study_first_submitted>
  <study_first_submitted_qc>July 30, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 6, 2021</study_first_posted>
  <last_update_submitted>August 6, 2021</last_update_submitted>
  <last_update_submitted_qc>August 6, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 13, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>RWTH Aachen University</investigator_affiliation>
    <investigator_full_name>Ayham Daher</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension, Pulmonary</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

